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Case Introduction 
Fibromuscular dysplasia (FMD) is a heterogeneous group of non-atherosclerotic, non-
inflammatory vascular diseases that can be classified into two subtypes based on their 
angiographic appearance: the multifocal type, with its typical string-of-beads pattern, and the 
unifocal type, presenting as a single focal stenosis.1,2 As these two FMD entities differ 
substantially with regard to clinical and histopathologic characteristics, it has been suggested 
that unifocal and multifocal FMD in fact represent two different vascular diseases.3 Recently, 
however, we observed a patient in whom imaging studies suggest the co-existence of unifocal 
and multifocal FMD in a single patient. 
  
 
Patient 
A smoking, 45-year-old, white woman was admitted to hospital because of progressive 
postprandial abdominal pain in the previous 3 weeks. Gastroscopy was normal, but CT-scan 
revealed a 80% stenosis of the celiac trunk and occlusion of the superior mesenteric artery (Figure 
1). Balloon angioplasty and stenting of the celiac trunk resolved her complaints, although this 
procedure was complicated by a dissection of the brachial artery. As the CT-scan showed no signs 
of calcification or thrombosis in the affected arteries and additional tests revealed no heart rhythm, 
lipid, coagulation, or inflammatory disorders, the etiology of these vascular abnormalities remained 
unclear. Therefore, she was referred to our outpatient clinic for further analysis.  
 
Discussion: Initial Differential Diagnosis 
Prof. Grossman: It may be a type of vasculitis and we need to see some laboratory 
evaluation of the possibility of vasculitis.  
 
Dr. van Twist: Yes, I think that is an excellent suggestion. I will show you it in a 
minute, the CRP and all the inflammatory markers are completely normal. So, there were 
no signs of inflammation by the time of admission.  
 
Dr. van Twist: Any other suggestions, except for vasculitis? 
 
Prof. Bursztyn: I would like to ask whether this woman had a loss of weight 
preceding to the symptoms? Sometimes when there is loss of fat, an angulation of the 
celiac axis occurs, and this angulation may be a stenosis and cause abdominal angina. 
Was there a history of substantial weight loss preceding the symptoms? 
  
Dr. van Twist: The post-prandial pain started only three weeks before the hospital 
admission, and then the weight was stable. Only the last week she lost 2 or 3 kg. The 
disease you are suggesting is the Wilkie syndrome, also called the superior mesenteric 
artery syndrome, and that results in compression of the duodenum by the superior 
mesenteric artery. It does not lead to a stenosis of the vessel itself. So, I don't think that's 
the case here. 
 
Dr. Spiering:  Were there any clues of atherosclerosis or a smoking history? 
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Dr. van Twist: She had a smoking history for a few years, and the CT of the 
abdomen revealed only two little calcification spots in the distal aorta, but not in the 
vessels that were affected.  
 
Prof. Rossi: My question is on the same line. Did the patient have familial 
hypercholesterolemia or severe hyperhomocysteinemia, because the differential 
diagnosis here is between atherosclerosis and FMD. 
 
Dr. van Twist: The lipid levels were completely normal, and the total serum 
homocysteine level as well. Her family history was not suggestive for familial 
atherosclerosis either. Therefore, with the lack of these risk factors, atherosclerosis was 
considered less likely. 
 
 
Prof. Rossi: Well, to get abdominal angina, you need to have occlusion of two out of the 
three vessels, and one with stenosis. You didn't tell us about the inferior mesenteric artery. 
Please do. 
 
Dr. van Twist: It was completely normal, completely open. 
 
Prof. Dominiczak: So, I have a different question. We are at a hypertension meeting, 
and we haven't heard anything about blood pressure of this patient. Could we hear a little 
more about her blood pressure, please? 
 
Dr. van Twist: When came in our outpatient clinic, we started with additional 
history taking. 
 
Patient History 
Upon history taking, several remarkable details were noticed. First, her medical history included 
a hypertensive crisis at the age of 36 years with blood pressure up to 240 mmHg systolic. This 
started rather abruptly (her blood pressure was normal one year before) and was currently well 
controlled with 3 antihypertensive drugs. In addition, she reported episodes of pulsatile tinnitus, 
which could occur in one or in both ears. One year ago, she underwent coronary angiography 
because of exertional chest pain with ST-segment elevation during exercise testing. The 
coronary angiogram showed no significant stenosis, but tortuosity of the coronary arteries was 
observed. 
 
Dr. Jennings:  Was that tortuosity of the coronary arteries noted at the time? 
 
Dr. van Twist: According to the the cardiologist’s report it was a little strange 
aspect of the distal coronary arteries. They didn't use the term tortuosity, but he noticed 
that it was not normal. 
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To summarize, we have a patient with visceral artery abnormalities, a stenosis of the 
celiac trunk, occlusion of the superior mesenteric artery, and additional history taking 
revealed a rapid onset hypertension, pulsatile tinnitus, and coronary tortuosity. Again, the 
question for the audience, what is your differential diagnosis now and what would you do 
next? 
 
Dr. Ratanjee: So, it looks like it's a disease that is affecting at multiple levels. I think you 
would either need a CT angiogram or an MRA of all of the blood vessels in the body, 
especially the medium-sized arteries. 
 
Dr. van Twist: Excellent suggestion, I think.  
 
Dr. Barigou:  Given the young age of the patient with the fact that she had multiple 
vessel involvement and the rapid onset of hypertension, the grade 3 hypertension is really 
important, we should seek for every secondary cause of hypertension practically because 
there is some involvement. Take a look to her renal arteries, if there is the same 
involvement and considering the abnormalities that were seen in her coronary arteries, 
couldn't we seek for Kawasaki disease that could give some coronary arteries in the same 
time a systemic disorder but is very rare in some conditions. That's my proposition. 
 
Prof. Persu:  Considering the additional history taking, each finding separately is 
not specific, but when we look at all the findings it's extremely suggestive for a wide-
spread FMD. You have the hypertension. The Americans have taught us that the 
presence of tinnitus, especially swooshing, as you mentioned, is quite suggestive of 
carotid FMD. Then, coronary tortuosity is found in patients with spontaneous coronary 
artery dissection, which is strongly linked with FMD. So, I would say the probability of 
FMD is very high now. 
 
Dr. van Twist: I think that's an excellent comment.  
 
 
Fibromuscular Dysplasia? 
Given the rapid onset hypertension, pulsatile tinnitus, and coronary tortuosity we suspected FMD 
as the underlying vascular disease causing the abnormalities in the visceral arteries, but 
presumably with renal artery involvement as well. Revision of the abdominal CT-scan indeed 
suggested a stenosis of the left renal artery. The right renal artery appeared to be normal. Some 
small calcifications were noted in the distal aorta, but not at the level of the renal arteries or celiac 
trunk. In order to establish the diagnosis of FMD, a catheter-based renal angiography was 
performed (Figure 2). This confirmed the presence of a solitary stenosis in the left renal artery, 
which was suggestive for unifocal FMD. However, in the right renal artery, a string-of-beads was 
observed, consistent with the diagnosis of multifocal FMD.  
 
Prof. Kroon:  So, does this change your diagnosis or does this change your ideas 
with respect to what the diagnosis should be? 
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Dr. Spiering:  No, it does not. I think it's typical for FMD, but what is really striking 
is that on the right renal artery you see a string of beads and on the left you see unifocal 
stenosis. 
 
Prof. Kroon:  Yes, indeed. I completely agree. Should that cause us to rethink the 
diagnosis? We have never seen a picture of the string of beads in one artery and unifocal 
stenosis on the other artery. We have seen unifocal disease on both arteries or in several 
sites in one patient, but not this combination.  
 
Dr. Spiering:  Well, actually that was my question to you. I've never seen such a 
case. 
 
Prof. Persu:  First about the focal lesion, how can you rule out that this is not 
atherosclerotic lesion, which is quite possible here? 
 
Prof Kroon:  Well, that's indeed what is very difficult, but we've been looking in 
detail in this patient to see whether there is atherosclerosis and as we said before, there 
are no signs of atherosclerosis anywhere, only small calcifications in the distal aorta. We 
have no other abnormalities in the aorta, and you know that atherosclerotic renal artery 
stenosis is an aortic disease, and there are no signs of that.  
 
Prof. Persu:  The second point is that with Dr. Jean-Philippe Lengelé 
(GHDC/UCL), we recently described three sisters with renal artery FMD, two have clear 
multifocal FMD and one has a focal stenosis on one side and on the other side mild 
irregularities compatible with multifocal FMD.4 So, I think the association is rare, but it 
does exist. Also, I am aware of at least one family from Paris in which one sib had 
multifocal FMD and the other unifocal FMD. It's quite different, because it's not the same 
patient, but still the fact that unifocal and multifocal FMD may occur in first-degree 
relatives suggests it can be the same disease. 
 
Prof. Kroon:  Thank you for your comment. I think I agree.  
 
Prof. Rossi:  Why the renal arteries were not looked at at the time when she 
was stented on the celiac trunk? At my institution when in a patient with hypertension, 
particularly if young, we usually do an examination of all of the arteries of the abdomen 
and also the epiaortic trunks, not only of the celiac trunk and the superior mesenteric 
artery. 
 
Prof. Kroon:  I completely agree with your comment, this should have been done 
the moment she was stented in the celiac trunk. However, this study was in another 
hospital, and at that time they didn't have the hint that this was FMD. Indeed, one should 
at least look into the renal arteries. 
 
 
Dr. Jennings:  Just in a similar way, did she have a renal bruit?  
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Prof. Kroon:  She didn't have a bruit. 
 
Dr. Spiering:  Your center is an expert center on flow measurements of the renal 
arteries. Did you do these measurements in this patient? 
 
Prof. Kroon:  In this patient we didn't do the flow measurements and that's due 
to shortage of 133Xenon (which is used for the flow measurements) at that time. 
Otherwise, of course, I would have shown you these data. 
  
 
Prof. Dominiczak: Could I ask a naïve question? Clearly in clinical practice at this 
stage we would say this is FMD. It could be one or two types, but this is a young woman. 
We would proceed to angioplasty, because we want to treat this condition. So, does it 
matter all that much that one renal artery is slightly different than the other? The only 
worry would be that one is atherosclerotic and the other is FMD. But if you could with all 
logical clinical arguments exclude atherosclerosis, for me, you would just proceed with 
action. 
  
Prof. Kroon: Well, you're completely right, but there may be a difference. If it's FMD, you 
only do the balloon dilatation, and if it's atherosclerosis you would prefer to put a stent on 
that left renal artery. So, there may be a difference. But, indeed, the discussion is a bit 
academic. So, our diagnosis.  
 
Diagnosis 
We report a case of a patient with multiple vascular lesions that are suggestive of two different 
types of FMD in single patient: multifocal FMD in the right renal artery and unifocal FMD in the 
celiac trunk and left renal artery. Presumably, the occlusion of the superior mesenteric artery is 
also related to FMD, either as a result of spontaneous dissection or progression of a severe 
stenosis.  
 
Since the co-occurrence of two FMD subtypes in one individual patient is rare, we considered 
alternative diagnoses. As there was no vascular tissue available for histological examination, the 
diagnosis had to be made on clinical information and imaging studies alone. However, in our 
opinion, there is not much doubt about the diagnosis of multifocal FMD, as the string-of-beads 
pattern that was observed in the right renal artery is very characteristic. Moreover, symptoms 
like pulsatile tinnitus and exertional chest pain (attributed to cervical and coronary tortuosity, 
respectively) are also often reported by patients with multifocal FMD.5,6 The solitary lesions in 
the celiac trunk and left renal artery, however, may have a different etiology than unifocal FMD. 
Yet, we found no clues for inflammatory diseases or syndromic abnormalities such as 
neurofibromatosis or Ehlers-Danlos syndrome. The most plausible alternative explanation would 
be that these lesions are caused by concomitant atherosclerosis, which is not uncommon in 
patients with multifocal FMD. The presence of (subtle) atherosclerotic changes in the aorta and 
cigarette smoking as a risk factor may point towards that. However, the imaging studies did not 
reveal any calcifications in or near the severe stenoses in the celiac trunk, superior mesenteric 
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artery, or left renal artery. Although we cannot fully rule out that these lesions are all caused by 
non-calcified soft plaques, we would have expected at least some calcification in case of diffuse 
atherosclerosis that already progressed to multiple clinically relevant stenoses. Therefore, we 
consider it most likely that the lesions in the celiac trunk and left renal artery are caused by 
unifocal FMD. 
This observation of co-existence of unifocal and multifocal FMD in a single patient was quite 
unexpected, as there are several reasons to assume that these two FMD subtypes are, in fact, 
two different diseases. First, and most importantly, the affected layer of the vessel wall differs 
between unifocal and multifocal FMD.1,2 In multifocal FMD, the medial layer is affected, with 
alternating areas of thick and thin medial fibroplasia that result in the typical string-of-beads 
appearance (as observed in the right renal artery of our patient). In unifocal FMD, however, 
fibroplasia of the intimal or adventitial layer is present over a shorter segment, resulting in a focal, 
solitary stenosis. Furthermore, patients with unifocal FMD are generally younger (26 vs. 40 years), 
more often male (31% vs. 17%), and have higher blood pressure upon presentation (157/97 
mmHg vs. 146/88 mmHg).7 In addition, the pathophysiological mechanisms leading to 
hypertension appear to differ between these entities, with preserved renal perfusion and normal 
renin secretion in multifocal FMD, but a classical pattern of renovascular hypertension with 
reduced renal blood flow and increased renin secretion in unifocal FMD.8 These differences in 
histological, angiographic, pathophysiological, and clinical characteristics do not point towards 
variations of a single disease, but rather towards two different diseases.3 That is presumably the 
reason why the co-occurrence of these two FMD subtypes in one individual patient is rare: the 
probability of co-occurrence of two relatively rare vascular diseases in one single patient is, 
statistically speaking, extremely low. Although several review articles reported that patients with 
both unifocal and multifocal lesions exist,1,9 these statements are (to the best of our knowledge) 
not supported by any original case descriptions in the literature. Histological studies have reported 
that two layers of the vascular wall can be affected in one single vessel segment,9,10 but that is 
fundamentally different than multifocal FMD in one artery and unifocal FMD in another. The lack 
of such case descriptions in the literature illustrates the rarity of this combination and supports the 
concept of two different diseases. Nevertheless, this appears to be the case in our patient, perhaps 
the exception that proves the rule. 
 
Prof. Rossi:  I find this a very interesting academic discussion, but so far we 
have not enough solid data to solve this dilemma between one single disease or two 
disease. Unfortunately, as you pointed out, we do not have the option to examine these 
arteries histopathologically and molecularly since the introduction of renal artery 
angioplasty. Hence, going back to Professor Dominiczak’s point, is this important to 
clarify if this is atherosclerosis or FMD? I had experience with quite a few patients with 
long-standing hypertension starting at the very early age and never screened for 
secondary forms, that developed atherosclerotic changes over time with vessel 
calcifications. In other words, these patients start with FMD and after 20 - 40 years, 
because of the raised blood pressure, the chronic activation of the renin-angiotensin-
aldosterone system and also because of aging and exposure to other risk factors they 
also develop atherosclerotic lesions, with worsening hypertension which often becomes 
severe and resistant to drug treatment. I think if I may say this, that with physicians 
following the “polypill approach” and giving up on early screening for secondary 
hypertension , we will see many more of these cases in the future. 
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Prof. Kroon:  Well, I completely agree with this comment. This is something we've 
seen already with a patient of 65 years old who presented with FMD and an atherosclerotic 
renal artery stenosis in one renal artery. So, it's a combination, and it's due to not 
diagnosing the FMD at early ages. But I think we have to decide now as to whether we 
should do something with this patient, and that may be a point of discussion. Are we going 
to do balloon angioplasty in this patient or not?  
 
Dr. Sharabi:  I think it is critical to perform balloon angioplasty. A few years ago, 
I think it was 2010, a study was published in Hypertension on the outcome of angioplasty 
in FMD,11 and apparently age is a major factor because you want to cure patients with 
FMD. So, at a certain age the likelihood that she will be cured and not need medication is 
critical. So, at her age, if I remember well the graph that looked at the age and response 
to treatment in terms of long-term response, she is about like 30 to 40% chances that 
she will be cured from her blood pressure. So, we must decide whether it's worth the 
angioplasty. The other thing, again, this goes back to what is the etiology? If it is 
atherosclerosis, then the likelihood is even less. Therefore, I think that age and the 
duration of the patient's hypertensive disease are two important factors that will tell you 
whether or not it's worth going for balloon angioplasty.  
 
Prof. Persu:  I think I would go for pressure gradient measurements in this 
patient, because we're not completely sure the focal lesion is FMD, so how will it 
respond, and the typical string of beads on the other side looks relatively mild. Also, we 
have learned from Professor Olin that with the same string of beads aspect you can have 
gradients from zero to a very high gradient. I agree there are no specific studies on 
pressure gradient measurements in FMD, as we discussed already, but still from a 
pragmatic point of view, I would do it for this patient. 
 
Prof. Kroon:  Well, if one proceeds to pressure gradient measurements along the 
abnormal artery, the difficulty still remains in what one should take as the cutoff levels of 
the difference in blood pressure between the pre-stenotic and the post-stenotic arterial 
segment. Interestingly, we have only data from studies in subjects with atherosclerotic 
renal artery stenosis and not in FMD. So, what would be the cutoff to decide to go for 
intervention or not. 
 
Prof. Persu:  Admittedly, we have no evidence-based specific cutoff for FMD, 
but again, if the gradient is near to zero, which is, I think, is possible here, what would 
you do? Would you revascularize only the artery with the focal stenosis, and in this case 
would you put a stent or not? The question is difficult to answer. 
 
Decision for Treatment 
As the trans-stenotic pressure gradient was relatively low (13 mmHg on the right side, 15 mmHg 
on the left), her blood pressure was well controlled, and kidney-size and renal function were 
normal, she was managed conservatively without renal artery intervention. 
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Prof. Kroon: We had some arguments for what we did. One argument is this curve 
(Figure 3).11 We have a 45-year-old lady in which the pretest chance of curing her 
hypertension would be something between 30 and 40%. Then, we had a well-controlled 
blood pressure with three antihypertensive drugs. Her systolic blood pressure was below 
140 mmHg. She had a normal kidney size, so no atrophic kidneys, especially on the left 
side. She had normal renal function with respect to eGFR. We did the transstenotic 
pressure gradient, and we measured on the right side a pressure gradient of 13 mmHg 
and on the left side a pressure gradient of 15 mmHg, which is somewhat less than 10% 
of a change. Although one can dispute this decision, we decided not to do a balloon 
angioplasty with this information. We decided to control her blood pressure level closely, 
and the moment there are significant changes in blood pressure level (without changes in 
medication) or changes in kidney function, we will review our current decision and may 
go for angioplasty at that time in this patient. But, of course, this is debatable, but that 
was our choice.  
 
Prof. Dominiczak:  So, could I ask you, what sort of follow-up? How carefully 
and frequently are you going to follow-up this patient, because of course lesions could 
progress. We've all seen, sometimes quite rapid, progression of renal artery stenosis, 
whatever the etiology. So, how frequently are you seeing this lady in your specialist 
clinic? 
 
Prof. Kroon:  We see her every three months, and we do our standard blood 
pressure measurements and once every six months we have a creatinine level in this 
patient and up until now everything has gone as we described here.  
 
Prof. Dominiczak: Okay. So, any comments on this management?  
 
Dr. Jennings:  Just a question of terminology. Do you consider then by this decision 
that this lady has renal artery disease but does not have renovascular hypertension? 
 
Prof. Kroon:  You're completely right. She has renal artery abnormalities, but we 
haven't shown that she has renovascular hypertension. 
 
Prof. Rossi:  Can you tell me where exactly you put your catheter for the pressure 
measurement? 
 
Prof. Kroon:  Yes. We came to the furthest point where we saw abnormalities, 
there we measured our blood pressure and we measured our blood pressure somewhere 
here for the left renal artery. So, really post-stenotic and post string of beads.  
 
Prof. Rossi:  The reason of my question is because I see theoretical problems 
with this measurement on several grounds. When you introduced a catheter you are 
narrowing the vessel and creating a gradient. Moreover, with multifocal FMD it is like 
when you are watering your garden and you have a number of bends of the tube: at the 
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end of the hose you have no water because you have no pressure. In other words, we 
are facing here multiple lesions in series, which taken individually may not look very 
severe, but add up in causing low perfusion to the kidney. Hence, one way around this 
difficulty could be to measure the resistivity within the kidney in the different poles and if 
you have a decreased resistivity index, this can be indirect evidence for the 
hemodynamic relevance of the stenosis. I don't know if you agree with it, but this is what 
we rely on at my institution. The important point here, however, is that one should look 
more at the heterogeneity of the values of the resistivity index across the different thirds 
of the kidney (upper, mid and lower) than at its absolute value. In fact, we found this to 
be more accurate in predicting the hemodynamic relevance of the lesions, particularly 
when you have multiple renal arteries and FMD involving just one of them. 
 
Prof. Kroon:  Well, we looked into duplex-echography studies of the renal 
arteries in the past, and did a careful study some years ago in our hospital. We found, 
however, that our results were not valid. So, we stopped doing measurements of the 
resistivity index, predominantly because of the fact that it's very operator-dependent. So, 
we didn't do the assessment in this case. There are case reports showing that you can 
do this with echo and show an increase resistive index, but unfortunately not in our 
hands.  
With respect to the catheter measuring pressure, the catheter should be as small as 
possible, otherwise it will wedge, and then you have, of course, no pressure at all. So, you 
can make your stenosis if you want to. 
 
Dr. Barigou:  You didn't show us the results of renin and aldosterone in this 
patient. 
 
Dr. van Twist: No, we didn't do it in this specific patient. The reason was that she 
was on antihypertensive medication with triple therapy. So, we didn't do a blood sampling 
for renin and aldosterone.  
 
Dr. Barigou:  Even though it could be valuable to do it before interpreting only 
imaging studies and not hormonal studies.  
 
Dr. van Twist: No, I would never advise to do a blood sampling under triple therapy. 
The results you get are very difficult to interpret. If you want to do it, you should stop all the 
antihypertensive drugs. Or bridge them with other antihypertensive drugs, such as alpha 
blockers or calcium antagonists that do not have interaction with the renin-angiotensin 
system. 
 
Dr. Barigou:  Those are the guidelines. 
 
Dr. van Twist: But in this case, we didn't stop the medication before, we just did 
this angiography. 
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Prof. Dominiczak: Okay. I think a very interesting case, and if I can be a prophet, I think 
it will get worse. I think we will invite the team to come back to one of our clinical 
pathological conferences to give us feedback two, three years on. So, the invitation stands.  
  
Summary 
 
In summary, we discussed a unique case of a patient in whom imaging studies suggest the co-
existence of multifocal and unifocal FMD in a single patient. Further research is needed to 
determine whether multifocal and unifocal FMD are subtypes of the same disease, or, in fact, 
represent two different vascular diseases that occurred simultaneously in one patient. Balloon 
angioplasty to treat hypertension appears to be effective in a subset of patients with FMD, but 
whether its effect can be predicted by measurement of the trans-stenotic pressure gradient 
remains unclear.   
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Figures 
Figure 1: 
 
 Contrast-enhanced computed tomography (CT) scan of the abdomen in the sagittal plane 
revealing a 70-80% stenosis of the celiac trunk (arrow). 
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Figure 2: 
 
Digital subtraction angiography of the aorta with the catheter positioned at the kidney level. Note 
the string-of-beads pattern in the right renal artery, the solitary stenosis in the left renal artery, 
and the stent in the celiac trunk. 
 
 
 
 
 
  
 16 
 
Figure 3: 
                               
Meta-regression analyses assessing the relationship between age and the hypertension cure 
rate after renal artery balloon angioplasty. Adapted from Trinquart L, Mounier-Vehier C, Sapoval 
M, Gagnon N, Plouin, PF. Efficacy of revascularization for renal artery stenosis caused by 
fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010;56(3):525-
32. 
 
 
 
